drugset / Trial / NCT00568321
RN624 For Pain Of Post-Herpetic Neuralgia
RandomizedParallel-groupTriple-blindTreatment
Summary
This study will test the efficacy and safety of two doses levels of RN624 versus placebo for the relief of pain caused by post-herpetic neuralgia (PHN).
Timeline
- Start
- 2007-12-19
- Primary completion
- 2008-12-20
- Completion
- 2009-01-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Tanezumab | Monoclonal antibody | 50 ug/kg | — |
| Comparator | Tanezumab | Monoclonal antibody | 200 ug/kg | — |